Purified urinary follicle stimulating hormone induces different hormone profiles compared with menotrophins, dependent upon the route of administration and endogenous luteinizing hormone activity

Human Reproduction

Volumn 11, Issue 9, 1996, Pages 1854-1858

  Fleming, R ^a   Chung, C C ^a   Yates, R W S ^a   Coutts, J R T ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Hormone profile; LH; Menotrophins; Purified urinary FSH

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN DERIVATIVE; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; TESTOSTERONE; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG PURITY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; PROGESTERONE BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; TESTOSTERONE BLOOD LEVEL;

EID: 0029802289     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019506     Document Type: Article

References (12)

1. Baird, D.T. (1983) Factors regulating the growth of the pre-ovulatory follicle in sheep and humans. J. Reprod. Fertil., 69, 343-352.
2. Cedars, M.I., Lapolt, P., Surrey, E. et al. (1990) Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval. Fertil. Steril., 53, 627-631.
3. Couzinet, B., Lestrat, N., Brailly, S. et al. (1988) Stimulation of ovarian follicular maturation with pure follicle stimulating hormone in women with gonadotropin deficiency. J. Clin. Endocrinol. Metab., 66, 552-556.
4. Dobbs, K.E., Dumesic, D.A., Dumesic, J.A. and Shapiro, S.S. (1994) Differences in serum follicle stimulating hormone uptake after intramuscular and subcutaneous human menopausal gonadotropin injection. Fertil. Steril., 62, 978-983.
5. Giudice, E., Crisci, C., Eshkol, A. and Papoian, R. (1994) Composition of commercial gonadotrophin preparations extracted from human post-menopausal urine: characterization of non-gonadotrophin proteins. Hum. Reprod. 9, 2291-2299.
6. Hillier, S.G., Smyth, C.D., Whitelaw, P.F. et al. (1995) Gonadotrophin control of follicular function. Horm. Res., 43, 216-223.
7. Hull, M.G.R., Armatage, R.J. and McDermott, A. (1994) Use of follicle stimulating hormone alone (urofollitropin) to stimulate the ovaries for assisted conception after pituitary desensitisation. Fertil. Steril., 62, 997-1003.
8. Le Cotonnec, J.Y., Porchet, H.C., Beltrami, V. and Howles, C. (1993) Comparative pharmacokinetics of two urinary follicle stimulating hormone preparations in healthy female and male volunteers. Hum. Reprod., 8, 1604-1611.
9. Le Cotonnec, J.Y., Porchet, H.C., Beltrami, V. et al. (1994a) Clinical pharmacology of recombinant human follicle stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH. Fertil. Steril., 61, 669-678.
10. Le Cotonnec, J.Y., Porchet, H.C., Beltrami, V. et al. (1994b) Clinical pharmacology of recombinant human follicle stimulating hormone (FSH). II. Single doses and steady state pharmacokinetics. Fertil. Steril., 61, 679-686.
11. Sagle, M.A., Hamilton-Fairley, D., Kiddy, D.S. and Franks, S. (1991) A comparative, randomised study of low-dose human menopausal gonadotropin and follicle stimulating hormone in women with polycystic ovarian syndrome. Fertil. Steril., 55, 56-60.
12. Zelinski-Wooten, M.B., Hutchison, J.S., Hess, D.L. et al. (1996) Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophin-releasing hormone antagonist-treated monkeys. Hum. Reprod., 10, 1658-1666.